TMEFF1 and uterine corpus endometrial carcinoma: GEPIA website analysis showed that the expression of TMEFF1 mRNA was significantly increased in ovarian cancer, uterine corpus endometrial carcinoma, and uterine carcinosarcoma, but decreased in glioblastoma multiforme, acute myeloid leukemia, and thyroid carcinoma (Fig. 1B).